Equifax Inc. EFX ← Back to all reports

Equifax Inc.

EFX · Industrials
A ★★★★ Buy
Oct 24, 2026 · Score 79 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $182.36
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $175.00 ($170.00–$180.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $211.20
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative Expected Return means the Price Target is below the report-date Current Price. This can occur even with a Buy or Strong Buy recommendation because recommendations follow a fixed mapping from the overall investment score, which combines business assessment, valuation and risk. This is a limitation of our score-based framework: a favorable recommendation does not always imply an attractive entry price. Consider the Price Target, Buy Zone and valuation analysis together.
Methodology →
+15.8%

Type A - Equifax Inc. (EFX) 20261024 Stock Analysis

📅 Equifax Key Upcoming Events

🏢 Step 1: Equifax Company Overview & Business Model

Q1-A1. What is Equifax?

Q1-A2. How Does Equifax Make Money?

Q1-A3. Equifax’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Equifax’s Competitors?

Q1-A5. Equifax Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Equifax’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Equifax Have a Durable Economic Moat?

Q2-A2. Is Equifax’s Growth Sustainable?

Q2-A3. How Does Equifax Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Equifax Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Equifax? (Margins & ROIC)

Q3-A3. What Drives Equifax’s Returns? (ROIC Breakdown)

Q3-A4. Are Equifax’s Earnings High Quality?

Q3-A5. Is Equifax’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Equifax Forensic Accounting & Dilution Review

Q4-A1. Does Equifax Have Accounting Red Flags?

Q4-A2. Is Equifax Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Equifax’s Cash Flow?

Q4-A4. Is Equifax Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Equifax Management & Shareholder Alignment

Q5-A1. Can You Trust Equifax’s Management? (Guidance Track Record)

Q5-A2. What Are Equifax Insiders Doing?

Q5-A3. Is Equifax’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Equifax Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Equifax Guidance

Q6-A2. What Is Equifax’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Equifax Catalysts & Price Triggers

Q7-A1. What Could Move Equifax Stock? (Top 3 Catalysts)

Q7-A2. Equifax’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Equifax Fairly Valued? Valuation Analysis

Q8-A1. Equifax’s Key Valuation Multiples

Q8-A2. Equifax vs Peers: Valuation Comparison

Q8-A3. Is Equifax Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Equifax? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From Equifax? (Reverse DCF Alternative)

Q8-A5. Equifax’s Hidden Asset & Stake Valuation

Q8-A6. Final Valuation Adjustment

Q8-A7. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Equifax? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Equifax?

Q9-A2. How Sensitive Is Equifax to the Economy?

Q9-A3. Equifax Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: Equifax Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Equifax? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Equifax’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Equifax’s Dependence on Mortgage and Employment Transactions Its Biggest Weakness?

Q2: Can Equifax’s Approximately 20x Forward P/E Be Justified by Its Data Franchise and Earnings Growth?

Q3: Can Equifax’s Workforce Solutions Maintain a 44% Operating Margin?

Q4: Will Equifax’s EFX.AI Investments Produce Sustainable Earnings and Cash-Flow Gains?

Q5: Could Equifax’s Círculo de Crédito Acquisition Strengthen Its Latin American Competitive Position?

Q6: Why Did Equifax’s Earnings Grow Faster Than Cash Flow in the First Nine Months of 2026?

Q7: Is Equifax’s $5.01B Net Debt a Material Threat to Its Shareholder Returns?

Q8: Could Regulation or a Cybersecurity Incident Permanently Damage Equifax’s Data Advantage?

Q9: Are Equifax’s Share Repurchases Creating Genuine Per-Share Value?

Q10: What Would Make Equifax a Stronger Long-Term Compounder by 2027?

Rating History

Rating History shows the Rating assigned on each report date. Only the latest report is available to read. Scores are omitted from the timeline because reports from different periods may follow different rating scales.

  1. 2026-07-15 A
  2. 2026-07-25 B
  3. 2026-10 A